PK and PD of Antibiotics for Treatment of Mycobacterium Abscessus Pulmonary Disease

NCT05676138 · Status: UNKNOWN · Type: OBSERVATIONAL · Enrollment: 40

Last updated 2023-01-09

No results posted yet for this study

Summary

Investigating the PK and PD indices in patients with M. abscessus complex-PD who will be treated with a currently recommended regimen, minimum inhibitory concentrations of organism, and their relation with clinical outcomes

Conditions

  • Nontuberculous Mycobacterial Pulmonary Infection

Interventions

OTHER

Measuring PK and PD indices in patients who receive conventional treatment

Measuring plasma concentration of commonly used antibiotics in NTM-PD

Sponsors & Collaborators

  • Seoul National University Hospital

    lead OTHER

Principal Investigators

  • Jae-Joon Yim, MD · Seoul National University Hospital

Eligibility

Min Age
20 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2023-01-01
Primary Completion
2024-12-31
Completion
2024-12-31

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT05676138 on ClinicalTrials.gov